New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
15:18 EDTSAP, MCRS, CRM, ORCLOracle deal for MICROS a near-term strategic positive, says Maxim
Maxim views Oracle's (ORCL) deal for MICROS (MCRS) as a near-term strategic positive that gives the company a more comprehensive solution in the verticals of food and beverage, hotels and retail than competitors SAP (SAP) and (CRM). Maxim keeps its Buy rating and $48 price target on Oracle.
News For ORCL;MCRS;SAP;CRM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 8, 2015
05:58 EDTORCLOptions expected to be active: EMC VMW IBM HPQ ORCL AA DB LL
Subscribe for More Information
October 7, 2015
07:06 EDTORCLAccenture chosen by San Francisco for financial management system
Subscribe for More Information
05:26 EDTORCLOracle implied volatility of 20 at lower end of index mean range
Subscribe for More Information
October 6, 2015
15:25 EDTSAPAmazon cloud announcement unlikely to sink Splunk, analysts say
Amazon (AMZN) appears to be signaling an expanded presence in cloud-based data analytics, sending shares of incumbents in the space lower and prompting several analysts to weigh in on the e-commerce giant's potential impact. AMAZON CLOUD: Amazon is expected to announce a new "big data" analytics addition to Amazon Web Services, according to an October 4 Wall Street Journal report. The article follows the launch last week of Amazon Elasticsearch, adding further data crunching capabilities to the company's cloud computing platform. Commenting on the news, William Blair analyst Bhavan Suri said that Splunk (SPLK) investor concerns over Amazon are overblown. Elasticsearch is likely to remain primarily a document search platform rather than a direct competitor to Splunk's offerings, while Amazon's expected analytics announcement looks more likely to challenge Tableau (DATA) and Qlik (QLIK), the analyst argues. Meanwhile, FBR analyst Daniel Ives said that a tangential move into the data analytics space "makes a ton of strategic and financial sense" for Amazon, as the market is only about 10% penetrated despite aggressive expansion from Microstrategy (MSTR), IBM (IBM), Microsoft (MSFT), SAP (SAP), and others. That said, Ives cautioned that Amazon's ability to again disrupt the cloud space with this latest entry appear limited in the near term, with many companies already showing preference for pure-play analytics firms. Amazon may ultimately have to make a larger acquisition by picking up a Qlik, Tableau, or Splunk to gain traction, the analyst contended. PRICE ACTION: Splunk shares are down fractionally in afternoon trading after some earlier volatility, while Tableau and Qlik are showing respective losses of roughly 3.14% and 1.86%.
07:17 EDTORCLStrategic News Service to hold a conference
Subscribe for More Information
October 5, 2015
19:50 EDTCRMSalesforce management to meet with JMP Securities
Subscribe for More Information
October 1, 2015
10:45 EDTCRMSalesforce calls active on renewed takeover chatter
Salesforce October weekly 70, 70.5, 71 and 71.5 calls are active on total call volume of 9,900 contracts (720 puts) on renewed takeover chatter. October call option implied volatility is at 43, October is at 37; compared to its 52-week range of 26 to 60. Active call volume suggests traders taking positions for upside price movement.
10:26 EDTCRMRumor: Salesforce moves up on renewed takeover chatter
05:56 EDTCRMSalesforce implied volatility of 35 at lower end of index mean range
Subscribe for More Information
September 30, 2015
06:58 EDTORCLOracle to furlough workers during holiday week, BI reports
Oracle has decided to close down during the holiday week between Christmas and New Year's, mandating that its employees pay for this furlough with paid vacation time, Business Insider reports, citing several sources. Some Oracle employees have been angered about this move that basically removes four days of paid time off from them, the report says. Reference Link
05:52 EDTCRMSalesforce implied volatility of 36 at lower end of index mean range
September 29, 2015
08:39 EDTORCLOracle Health Sciences adds 93 biopharma customers
Oracle (ORCL) Health Sciences announced that 93 emerging biopharma organizations worldwide have become new customers in the past year, adopting Oracle Health Sciences solutions to succeed in this rapidly evolving market and deliver drugs to patients faster. Organizations, including Accera and NewLink (NLNK), selected Oracle Health Sciences solutions to manage their end-to-end clinical trial processes, boost clinical development productivity, facilitate compliance, and build scalable, affordable platforms for growth.
September 28, 2015
10:08 EDTCRMTableau price target lowered to $75 at Summit Research on competition concerns
Summit Research analyst Srini Nandury said the firm's channel checks indicate that Tableau's (DATA) software competition will intensify from Salesforce (CRM), Qlik (QLIK) and PowerBI. The analyst thinks Tableau's string of large "beat and raise" quarters will come to an end since most of the "low-hanging fruit" seems to have been picked and the company will need to work harder to acquire new customers. Nandury keeps a Hold rating on Tableau and cut the firm's price target on the stock to $75 from $80.
September 25, 2015
12:48 EDTCRMSalesforce says does not support CISA
Subscribe for More Information
08:24 EDTCRMSalesforce checks positive, says Oppenheimer
After attending Salesforce's conference, Oppenheimer says that more enterprises were represented, indicating that the company's share of that market could be increasing, according to the firm. Oppenheimer adds that the company's platform strategy is becoming more popular with customers, and could enable it to monetize its large installed base. The firm reiterates an $80 price target and Outperform rating on the shares.
05:40 EDTCRMSalesforce implied volatility of 32 at lower end of index mean range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use